Adial Pharmaceuticals, INC.
SEC CIK 1513525 · ADIL · last insider filing 2026-06-29
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Davidson Matt | Director · Chief Development Officer | filed 2026 - 2026 |
| Young Wendy B. | Director | filed 2026 - 2026 |
| Claiborne Cary J | Director · Chief Operating Officer | filed 2021 - 2026 |
| Goodman Tony | Director · Chief Operating Officer | filed 2018 - 2026 |
| Anderson J. Kermit | Director | filed 2018 - 2026 |
| Schuyler Kevin | Director | filed 2018 - 2026 |
| Gilliland Robertson H. | Director | filed 2018 - 2026 |
| Newman James W. Jr. | Director | filed 2018 - 2025 |
| Truluck Joseph | Director · Chief Financial Officer | filed 2018 - 2024 |
| Johnson Bankole A. | Director · Chief Medical Officer | filed 2018 - 2023 |
| Stilley William B. III | Director · Chief Executive Officer | filed 2018 - 2023 |
| Reich Jack W | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Shah Vinay | Chief Financial Officer | filed 2024 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.